Published • loading... • Updated
NaNotics Study Demonstrates New Nanotechnology Approach to Cancer Immunotherapy
Summary by Business Wire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
NaNotics Study Demonstrates New Nanotechnology Approach to Cancer Immunotherapy
MILL VALLEY, Calif.--(BUSINESS WIRE)--New peer-reviewed research from Mayo Clinic and NaNotics LLC demonstrates a novel approach to cancer immunotherapy: engineered adsorptive nanoparticles called NaNots® selectively deplete a soluble protein that tumors use to suppress immune response and enable tumor growth. In the study, “Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control,” published in the …
·Crystal River, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
